Related by context. All words. (Click for frequent words.) 71 miRview TM meso 70 miRview 70 miRview squamous 68 miRview ™ squamous 67 miRview mets 67 miRview TM mets 67 miRview TM squamous 67 miRview TM 66 miRview ™ mets 66 tests miRview TM 66 miRview meso 65 Septin9 65 VeriStrat 63 differentiate squamous 63 Cervista HPV HR 62 Oncotype DX colon cancer 62 NMP# 62 Tr DNA 62 Epigenomics proprietary 62 epithelial tumors 62 ResponseDX Lung TM 61 Nucleic Acid Detection Immunoassay 61 Squamous 61 NSCLC tumors 61 cardiac perfusion 61 eTag assays 61 immunohistochemistry IHC 61 squamous 61 miRview ™ meso 61 Xanafide 61 VerifyNow P#Y# 61 p# biomarker 61 PITX2 61 EarlyCDT Lung 61 sDNA 60 Flow cytometry 60 guaiac 60 ResponseDX Colon TM 60 QuadraSphere 60 IDI MRSA 60 Septin 9 60 EUS FNA 60 PROLARIS 60 cell lysate 60 metastatic neuroendocrine tumors 60 kidney urologic 60 pancreatic adenocarcinoma 60 VeraCode 60 histological subtype 60 BACcel 60 microRNA profiling 60 miRNA biomarkers 60 targeted radiotherapeutic 60 prostate carcinoma 60 Immunohistochemical staining 60 pilocytic astrocytomas 60 gene methylation 59 Corus CAD 59 UGT#A# 59 fallopian tube cancers 59 APTIMA HPV 59 AttoSense 59 miRview ™ 59 FDG PET imaging 59 Prostate Px + 59 LungAlert TM 59 multigene expression test 59 Radient Pharmaceutical current 59 breast carcinomas 59 DNA methylation biomarker 59 Rosetta Genomics microRNA 59 NanoChip R 59 immunochemical fecal occult 59 ChemoFx 59 clinico pathological 59 completely resected 59 UroVysion 59 urothelial carcinoma 59 assay detects 59 NMIBC 59 genetic biomarkers 59 HDA GT# TM 59 HER2 expression 59 immunohistochemical 59 TMPRSS2 ERG 58 papillary renal cell carcinoma 58 NADiA 58 RQ PCR 58 CellSearch System 58 ImmuKnow R 58 FLT3 58 microRNA biomarkers 58 Her2/neu 58 gefitinib Iressa 58 Alfacell proprietary ribonuclease 58 immunohistochemical analysis 58 fluorodeoxyglucose positron emission tomography 58 molecular biomarkers 58 urine cytology 58 preoperative staging 58 haematopoietic 58 mucinous 58 nonsmall cell lung cancer 58 immunochemical 58 viral nucleic acids 58 acid phosphatase PAP 58 FullTerm 58 qRT PCR 58 thymidylate synthase TS 58 ADVIA Centaur 58 Hepatocellular Carcinoma HCC 58 molecular profiling 58 Surface Plasmon Resonance SPR 58 genomic proteomic 58 tubulin inhibitor 58 adenomatous 58 malignant nodules 58 Genetic Analyzer 58 colonography 58 biologic therapeutics 58 MammaPrint R 58 ResponseDX 57 xMAP Technology 57 methylation markers 57 Interferon alfa 57 HIFU therapy 57 noninvasive diagnostic 57 differentially expressed genes 57 qualitative serum 57 Scintigraphy 57 KRAS mutation status 57 SPECT CT imaging 57 carcinoma HCC 57 florbetaben 57 CT Colonography 57 benign neoplasms 57 PCa 57 HER2 overexpression 57 quantitative PCR 57 sestamibi 57 Fecal occult blood 57 mertansine 57 Immunohistochemistry 57 Affymetrix microarray technology 57 gastric carcinoma 57 trastuzumab DM1 T DM1 57 BladderChek 57 molecular diagnostic assays 57 essential thrombocythemia 57 kinase profiling 57 MAGE A3 57 FDG-PET/CT 57 ResponseDX Lung ™ 57 metastatic pancreatic 57 Epidermal Growth Factor Receptor 57 Azedra ™ 57 proteomic analysis 57 radiologic imaging 57 sputum cytology 57 cytogenic 57 PCR assay 57 index assay IVDMIA 57 splice variants 57 cisplatin resistant 57 #S rRNA gene 57 DIGE 57 DNA methylation biomarkers 57 renal tumors 57 PIK3CA 57 mutational analysis 57 MassARRAY platform 57 busulfan 57 bronchoalveolar lavage 57 AFRS TM 57 OnDose TM 57 ASCUS 57 enzyme immunoassay 57 computerized axial tomography 57 aCGH 56 recurrent NSCLC 56 HERmark 56 Immunoassays 56 PNA FISH TM 56 fine needle aspiration 56 chemoresistant 56 Axial Biotech 56 CupPrint 56 Trofex 56 near infrared spectroscopic 56 histological diagnosis 56 ultrasensitive method 56 FISH fluorescence 56 peritoneal carcinomatosis 56 BRAF V#E mutation 56 Western Blotting 56 NPM1 mutation 56 Onalta TM 56 perfusion imaging 56 DNAWitness Y 56 microsatellite instability 56 Capsule endoscopy 56 KRAS mutation 56 whole genome genotyping 56 underwent surgical resection 56 positron emission tomography computed 56 immunohistochemical staining 56 noninvasive prenatal genetic 56 prognostic biomarker 56 CTAP# Capsules 56 metaplasia 56 anti CD# antibodies 56 mSEPT9 56 tumoral 56 molecular biomarker 56 NuroPro PD 56 ProstaScint 56 Lymphocytic 56 hc2 56 careHPV 56 F FDG PET 56 progesterone receptor PR 56 Tem PCR 56 PrevOnco 56 ALTROPANE 56 molecular diagnostic assay 56 ChIP chip 56 T#I [002] 56 haematologic 56 colorectal cancer CRC 56 micrometastases 56 transthoracic 56 molecular assays 56 LEUKINE 56 HuMax 56 cervical carcinoma 56 miRNA assays 56 PCA3 assay 56 comparative genomic hybridization 56 NuroPro R 56 reagent kits 56 AdnaTest 56 Human Leukocyte Antigen 56 vivo fluorescence imaging 56 multiplex assay 56 HE4 test 56 situ hybridization FISH 56 K ras mutations 56 Histopathologic 56 Xcellerated T Cells 56 GeneSightRx 56 PCA3 gene 56 PGxPredict 56 lobular carcinoma 56 diagnostic prognostic 56 WavSTAT 56 Cepheid GeneXpert 56 situ LCIS 56 antiangiogenic agent 56 node metastases 56 Ibis T# 56 Dural Sealant 56 methylated DNA 56 PathFinderTG 56 bioFILM PA ™ 56 CINtec ® PLUS 56 Mutation Detection 56 ELISpot 56 triple quadrupole mass spectrometers 56 Alternans 56 photodynamic treatment 56 CLIA laboratory 56 deCODE AF TM 56 prognostic markers 56 magnetic resonance angiography MRA 56 cytological 56 Epi proColon 56 Optical coherence tomography 56 prostate cancer PCa 56 nested PCR 56 myeloproliferative 56 multiplex PCR 56 diagnose coronary artery 56 thoracoscopic lobectomy 56 FFR measurements 56 KRAS oncogene 56 vitro assay 56 Respiratory Virus 56 BCG refractory 56 Circulating tumor cells 56 Pharmacogenetic 56 VeraTag 56 theranostic 56 malignant pleural mesothelioma 56 histopathological 56 ProteinChip 56 Pathwork Diagnostics Laboratory 56 K RAS 56 tumor specific antigen 55 opto acoustic 55 percutaneous biopsy 55 ThinPrep System 55 metastatic lymph nodes 55 Upregulation 55 Mammostrat 55 carcinoid tumors 55 mutated K ras 55 pharmacogenetic tests 55 COR Analyzer 55 deCODE ProstateCancer TM 55 ductal adenocarcinoma 55 CIN2 + 55 Prognostic Value 55 HG PIN 55 Intra operative 55 induced macular edema 55 TRUS 55 serum protein biomarkers 55 ovarian breast 55 pain palliation 55 predictive biomarker 55 Cerashield 55 multiplexed assays 55 Abbott ARCHITECT 55 Molecular Diagnostic 55 Vitro Diagnostic IVD 55 clade B 55 Computed tomography 55 Xelox 55 anti JCV antibodies 55 prostate carcinomas 55 transcranial Doppler ultrasound 55 Sentinel Lymph Node Biopsy 55 Degarelix 55 ESBA# 55 artery embolization 55 CYP#A# CYP#D# 55 diagnostic biomarker 55 Cologuard 55 ELISPOT 55 KRAS BRAF 55 Telatinib 55 diagnostic modality 55 gastric adenocarcinoma 55 CLIA certified laboratory 55 epoetin alpha 55 diagnostic biomarkers 55 Haptoglobin 55 micrometastasis 55 protein biomarker 55 diagnostic assays 55 Mutational 55 cobas 55 MGd 55 cellular immunotherapy 55 situ hybridization 55 HIV1 55 transrectal ultrasound guided 55 CLIA certified laboratories 55 transfection reagents 55 breast cancer subtypes 55 multi analyte 55 DHPLC 55 E. faecalis 55 Companion Algorithms 55 VitiGam 55 humanised antibody 55 OnDose 55 oncoFISH cervical 55 CellSearch ™ 55 EliA 55 intravesical therapy 55 pretargeting 55 assay kits 55 Fine needle aspiration 55 hamartomas 55 EBUS 55 PET tracers 55 MAGE A3 ASCI 55 thymoma 55 Alkaline Phosphatase 55 PreGen Plus 55 Fractional Flow Reserve 55 balloon brachytherapy 55 VKORC1 55 PET CT scans 55 LVNC 55 LightTouch 55 clinicopathologic 55 Abdominal ultrasound 55 metabolomics driven 55 ColonSentry ™ 55 ResponseDX ™ 55 Endoscopic ultrasound 55 hepatocellular carcinomas 55 Mutation Analysis 55 immunoglobulin genes 55 urine dipstick 55 CellOptics platform 55 flow cytometry morphology 55 genomic profiling 55 Antigen CEA 55 endocrine therapies 55 BD GeneOhm 55 BCR ABL mutations 55 cytogenetic 55 vaginal lesions 55 computed tomographic 55 PEGylated interferon 55 Fludase 55 CINtec R 55 Hurthle cell 55 EP #R 55 POTELLIGENT ® 55 proton MR spectroscopy 55 Agilent microarrays 55 biliary tract cancer 55 Illumina genotyping 55 pulmonary angiography 55 cell adhesion molecule 55 colorectal lung 55 Fludara ® 55 arthrography 55 immunodiagnostic 55 HLA DQ 55 Contrast Agent 55 MDCT angiography 55 analyte specific 55 replicon 54 xTAG 54 ARCHITECT HIV 54 automated immunoassay 54 fetal fibronectin test 54 colorectal liver metastases 54 pretreatment serum 54 Computed Tomographic 54 serum biomarker 54 locoregional 54 HepaMate 54 SIR Spheres 54 CaPSURE 54 Xpert MRSA 54 RT qPCR 54 ChIP Seq 54 biomarker assay 54 NMP# BladderChek 54 OncotypeDX 54 Aureon 54 flurpiridaz F 54 NGAL 54 predictive biomarkers 54 tumorigenicity 54 sonographically guided 54 Neisseria gonorrhoeae 54 ProFlu + 54 Elastography 54 endoglin 54 neoadjuvant therapy 54 hyperoxaluria 54 KRAS status 54 thyroglobulin 54 aggregated Abeta 54 P2V TM 54 CaP 54 druggable targets 54 multiplex assays 54 carcinoid 54 S. maltophilia 54 renal biopsy 54 inactivating mutations 54 miRNA profiling 54 PREVU i 54 FFPE 54 pancreatic endocrine 54 gastrointestinal stromal tumors GIST 54 MTWA testing 54 Digital Mammographic Imaging 54 histopathologic findings 54 bioFILM PA TM 54 OncoVEX 54 CellPort Technologies 54 quantitative gene expression 54 ImmunoCAP ® 54 Qdot 54 Onko Sure ® 54 Chlamydia trachomatis 54 #F FDG 54 quantitative RT PCR 54 GNAQ 54 detecting colorectal cancer 54 ThinPrep R 54 histopathologic 54 malignant polyps 54 Genomic Grade 54 TOP2A 54 Breast Cancer Assay 54 PC Detect SM 54 Tomography SPECT 54 pT3 54 pelvic malignancies 54 BioMAP 54 PD2i 54 tyrosine kinase receptor 54 SensoLyte ™ 54 quantitative cytology 54 immunoblotting 54 K ras 54 Pathwork Tissue 54 Histologic 54 hematologic disorders 54 stage IIIA 54 ErbB2 positive 54 insertion deletion 54 mRCC 54 pelvic ultrasound 54 PNH patients 54 pancreatic lung 54 bisulfite sequencing 54 metastatic RCC 54 VERSANT 54 optical coherence tomography 54 x ray angiography 54 ResponseDX Colon ™ 54 ELISA assays 54 Western blotting 54 pT2 54 cytologic 54 DNAWitness Mito 54 Onalta 54 positron emission 54 neoplasm 54 pharmacogenetic test 54 Affymetrix GeneChip 54 proteomics bioinformatics 54 reaction PCR 54 amplified nucleic acid 54 Accelerated Partial Breast Irradiation 54 invasive carcinoma 54 FGFR3 54 Myocardial Perfusion Imaging 54 RNA seq 54 ADPKD 54 computed tomographic scans 54 Hemopurifier 54 phenotyping 54 curative therapy 54 radiotracers 54 DermTech International 54 Microwave Ablation System 54 PacBio RS 54 ELISA kit 54 cartilage lesions 54 KRAS mutations 54 Hedgehog Pathway Inhibitor 54 virotherapy 54 NPM1 54 multiplexing capability 54 transcranial Doppler 54 Supplementary Table 54 MALDI TOF 54 mSEPT9 biomarker 54 Quantitation 54 LRAT 54 proteomic biomarkers 54 trabectedin 54 Genotyping Test 54 myocardial perfusion 54 diagnosing coronary artery 54 Cervista HPV 54 thalidomide Thalomid 54 agarose gel electrophoresis 54 MelaFind R 54 LungSign TM 54 nodal metastasis 54 Onalta ™ 54 PET imaging 54 Hair follicle 54 noninvasive imaging 54 xTAG Cystic Fibrosis 54 annexin 54 BACcel ™ 54 KRAS variant 54 needle aspiration 54 D Dimer 54 myeloproliferative disorders 54 antibody arrays 54 ResponseDX genetic 54 sensitivity specificity 54 HuMax HepC 54 MSH2 54 pediatric malignancies 54 bladder carcinoma 54 cardiac troponin T 54 histone deacetylase HDAC 54 commercialized Analyte Specific Reagents 54 PCA3 test 54 osteoinductive 54 Cathepsin B 54 QPCR 54 syngeneic 54 Single Photon Emission Computed 54 Cardio3KG 54 T SPOT.TB 54 NMR LipoProfile test 54 Cardiac Marker 54 TPMT 54 SPECT CT 54 pulmonary metastases 54 Digene HPV Test 54 medically inoperable 54 occult metastases 54 affinity ligands 54 BSGI MBI 54 molecular imaging radiopharmaceutical 54 Chronix 53 tissue microarray 53 PROGENSA R 53 Illumina GoldenGate 53 biomarker 53 bioluminescent imaging 53 multidetector row 53 Hybrid Capture 53 PCA3 53 multiplex immunoassay 53 transabdominal 53 YONDELIS 53 Analyte 53 variant allele 53 HybSelect 53 #F FDG PET 53 Octreolin 53 esophageal carcinoma 53 MassARRAY R 53 Mass Spectrometry MS 53 radionuclide therapy 53 SPECT imaging 53 microbiologic 53 DNA methylation markers 53 hematopoietic cancers 53 HuMax Wnt 53 cytoreductive nephrectomy 53 Radical prostatectomy 53 Tesmilifene 53 ThinPrep Pap Test 53 PITX2 methylation 53 cervical cancer precursors 53 immunoblot 53 CAP accredited CLIA 53 tomography PET 53 V#E 53 transvaginal sonography 53 optical coherence tomography OCT 53 CyPath ® 53 cTnI 53 ColoMarker 53 radical nephrectomy 53 Immunohistochemical analysis 53 gene amplification 53 hypermethylated 53 differential gene expression 53 radioimmunotherapy RIT 53 Illumina Solexa 53 NuroPro ® diagnostic 53 WaferGen SmartChip Real 53 scintigraphic 53 CFTR cystic fibrosis transmembrane 53 abnormal cytology 53 TIMP 1 53 synovial tissue 53 initiate Phase 1b 53 AtherOx 53 gene expression microarrays 53 HPV genotyping 53 Activity Assay 53 Quantitative PCR 53 investigational therapies 53 HERmark assay 53 magnetic resonance spectroscopy MRS 53 percutaneous aortic valve 53 tiapamil 53 hepatoma 53 mTOR inhibitors 53 quantitative PCR qPCR 53 nCounter Analysis System 53 BeadArray 53 surgically resectable 53 resectable 53 AviaraDx 53 APiX 53 Viatronix V3D Colon 53 Sentinel lymph node 53 xMAP technology 53 antisense oligonucleotides 53 lipoprotein associated phospholipase 53 myeloproliferative diseases 53 Multivariate logistic regression 53 Cardiolite ® 53 PET tracer 53 PREVU * LT 53 histologic findings 53 investigational molecular imaging 53 intergenic regions 53 Trichophyton rubrum 53 multislice CT 53 beta lactams 53 Roche AmpliChip 53 nonmetastatic 53 Peptidomics 53 GeneSearch BLN Assay 53 HLA typing 53 VATS lobectomy 53 epigenetic therapies 53 ^ Tc 53 promoter methylation 53 dosimetric 53 oligonucleotide arrays 53 Pertuzumab 53 nasopharyngeal swabs 53 breast carcinoma 53 menstrual stem cell 53 Single Nucleotide Polymorphism SNP 53 benign nodules 53 transcriptome sequencing 53 IPAH 53 ALTTO 53 FAMILION 53 vinca alkaloid 53 Optical Coherence Tomography 53 Prognostic 53 SensoLyte ® 53 thoracolumbar spine 53 aneuploidies 53 transient elastography 53 S. aureus isolates 53 glycosylated 53 phosphoprotein 53 reslizumab 53 freestanding diagnostic imaging 53 Cardiotoxicity 53 ELISA assay 53 powder diffraction 53 somatic mutations 53 CCX# 53 prostatic adenocarcinoma 53 abdominal computed tomography 53 vimentin 53 prognostic indicators 53 myeloid 53 obstructive coronary artery 53 transesophageal echocardiography 53 kinase assay 53 Caris MPI 53 NRTI resistance 53 adipose derived stem cells 53 Sequencing Systems 53 Seeplex 53 venous thromboembolism VTE prophylaxis 53 VerifyNow 53 SELDI 53 Electronic Brachytherapy System 53 compound PMX # 53 TearLab TM 53 JAK2 mutation 53 HBsAg 53 mutational status 53 SNP Genotyping 53 prognostic variables 53 genomic biomarker 53 dimensional computed tomography 53 presymptomatic 53 Kit v2 53 MGUS 53 TMPRSS2 ERG fusion 53 nodal dissection 53 HemeScan 53 ABCB1 53 NovaBay Aganocide compounds 53 HER2 gene 53 recurrent bladder 53 adenomatous polyps 53 Imaging BSGI 53 Olerup SSP 53 PGxHealth FAMILION 53 transcriptomic 53 tumor biopsies 53 diagnose Alzheimer disease 53 spiral computed tomography 53 Annexin V 53 PRESEPT 53 iPLEX 53 LTQ Orbitrap 53 immunological diseases 53 Phase Ib study 53 OvaDx 53 pancreatic cysts 53 polyomavirus nephropathy 53 CYP#C# [002] 53 tumor subtypes 53 mediastinitis 53 coronary arteriography 53 Cervista 53 LHRH receptor positive 53 anti infective treatments 53 ELISAs 53 histologic examination 53 Abbott m# 53 Crystalens AO 53 LTBI 53 abnormal p# 53 tumor hypoxia 53 lymphatic mapping 53 conventional coronary angiography 53 advanced adenoma 53 Cystatin C 53 prognostic indicator 53 gene expression assays 53 Protelos R 53 Transcriptome 53 OVA1 53 treat brain aneurysms 53 scintigraphy 53 radiotherapy RT 53 Lenalidomide 53 advanced adenomas 53 TriGrid 53 quantitate 53 neoplastic 53 neovascular 53 transfection reagent 53 microwell plate 53 Clinical Validation 53 Epstein Barr Virus EBV 53 preoperative diagnosis 53 neratinib 53 V3D Colon 53 Accuray CyberKnife 53 Quantitative RT PCR 53 gastric carcinomas 53 Fc gamma receptor 53 microarray experiments 53 ^ sup #m 53 PD2i ® 53 Biophysical# 53 ImmunoCAP 53 Ag Ab Combo 53 differentially regulated 53 HER2 positive cancers 52 coronary computed tomography 52 chromosomal mutations 52 stratify patients 52 EECP R 52 Roche LightCycler ® 52 CT angiography CTA 52 NeutroSpec TM 52 anti fibrotic 52 Cardica Microcutter XPRESS 52 multimodality imaging 52 therapeutic monoclonal antibodies 52 Virtual Histology 52 AlloMap 52 Histological 52 Genotypes 52 metastatic renal cell carcinoma 52 Li Fraumeni 52 TGFBR1 * 6A 52 FDG PET 52 rxRNA 52 Spartan RX CYP#C# 52 duplex ultrasonography 52 SNP genotyping 52 Nucleic acid 52 fusion enhancers 52 lung nodule 52 RUO 52 molecular cytogenetic 52 serologic 52 Abbott RealTime 52 malignant prostate 52 CFTR gene mutations 52 JAK inhibitors 52 Lymphoseek ® 52 Interferon beta 52 IgM antibody 52 prostate cancer CaP 52 protein biomarkers 52 CYP#C# [001] 52 putative biomarkers 52 AspirinWorks 52 vivo preclinical 52 fluorescence imaging 52 EGFR TKIs 52 GAMMAGARD 52 AGHD 52 Single Molecule Array SiMoA 52 iChemVELOCITY 52 Comparative Genomic Hybridization 52 metabolomic profiling 52 colon capsule endoscopy 52 Immunohistochemical 52 prospectively defined 52 FISH probes 52 pharmacogenetic testing 52 STRIDE PD 52 Axiom Genotyping Solution 52 Zemiva TM 52 endoscopic ultrasound 52 FDG PET CT 52 IL#B 52 Hemospan 52 Cloretazine 52 histopathologic examination 52 genomic alterations 52 differentiated thyroid 52 Vocada Veriphy 52 HRCT 52 microarray analysis 52 HTS assay 52 microdeletions 52 xMAP 52 thyroid nodules 52 Illumina Infinium 52 germline mutations 52 interleukin IL 52 TLR antagonists 52 sCJD 52 Stretta System 52 Symadex 52 Onko Sure TM 52 cytolytic 52 NMP# BladderChek Test 52 biomarker identification 52 delipidation 52 LRP5 52 Computed tomographic 52 SELDI TOF 52 KRAS gene mutations 52 Trandolapril 52 genomewide 52 fetal aneuploidy 52 COLD PCR 52 coronary artery stenosis 52 Time PCR 52 vaginalis 52 BREVAGen ™ 52 Flow Cytometry 52 protein neuraminidase 52 blood serum biomarkers 52 rhBMP 2 52 Luminex xMAP technology 52 PreGen Plus TM 52 homodimer 52 reagent kit 52 vesicular stomatitis virus 52 breast cancer metastasis 52 Angiographic 52 splice junctions 52 poly ADP ribose polymerase 52 fluoropyrimidine 52 PreDx DRS 52 RECEPTORS LLC 52 bone scintigraphy 52 gynecologic procedures 52 QuantiFERON 52 BD MAX 52 BC SeraPro ™ 52 BioPlex 52 Electronic Brachytherapy 52 punctal plug delivery 52 Positron emission tomography 52 Prostate Cancer Progression 52 PI3K AKT 52 Cellvizio 52 LungExpress Dx TM 52 cervical cytology 52 Neo Bladder Augment 52 identify protein biomarkers 52 subsidiary AION Diagnostics 52 enterococcal 52 DEV DA TOMAR NEXT 52 D dimer 52 LabChip Dx 52 α β 52 Lewy bodies DLB 52 surrogate markers 52 proteomic 52 multidetector 52 NicAlert 52 hematological relapse 52 MTHFR gene 52 methicillin susceptible Staphylococcus aureus 52 ParAllele 52 LC-MS/MS 52 stereotactic radiotherapy 52 radioiodine therapy 52 TAXUS Express Stent 52 XmAb ® 52 microalbumin 52 prostate cancer metastases 52 Assay Kits 52 Molecular imaging